Show simple item record

dc.contributor.authorSchlabach, Martin
dc.contributor.authorDye, Christian
dc.contributor.authorKaj, Lennart
dc.contributor.authorKlausen, Silje
dc.contributor.authorLangford, Katherine
dc.contributor.authorLeknes, Henriette
dc.contributor.authorMoe, Morten Kaare
dc.contributor.authorRemberger, Mikael
dc.contributor.authorSchøyen, Merete
dc.contributor.authorThomas, Kevin
dc.contributor.authorVogelsang, Christian
dc.date.accessioned2020-12-11T13:15:49Z
dc.date.available2020-12-11T13:15:49Z
dc.date.issued2009
dc.identifier.isbn978-82-425-2087-6
dc.identifier.issn0807‐7207
dc.identifier.urihttps://hdl.handle.net/11250/2718719
dc.description.abstractOn behalf of SFT, NILU, NIVA, and IVL monitored pharmaceuticals, hospital-use pharmaceuticals, aquaculture medicines and personal care products in samples from hospital effluent water, wastewater treatment facilities, seawater, marine sediment, and blue mussels in samples collected in 2008 as a part of a screening. The detected concentrations of the compounds included in this report were compared with their known ecotoxicological effect concentrations. For most compounds toxicity data are available for a few species, therefore a safety factor of 1000 was used. Based on this simple risk assessment, the compounds tamoxifen, morphine, EDTA, butyl paraben,lauryl sulfate, and laureth sulfate are of some environmental concern. The compounds carbamazepine, cetrimonium, diethyl phthalate, naproxen, and propranolol are of environmental concern due to their presence in receiving compartments and their reported ecotoxicological effects.
dc.language.isoeng
dc.publisherNILU
dc.relation.ispartofNILU OR
dc.relation.ispartofseriesNILU OR;13/2009
dc.relation.ispartofseriesStatlig program for forurensningsovervåking; 1046/2009
dc.relation.ispartofseriesTA-2508/2009
dc.subjectLegemidler
dc.subjectNarkotika
dc.subjectKosmetiske produkter
dc.subjectMiljø
dc.subjectMiljøgifter
dc.subjectMiljøkjemi
dc.subjectKosmetikk og legemidler
dc.subjectMiljøovervåkning
dc.titleEnvironmental screening of selected organic compounds 2008. Human and hospital-use pharmaceuticals, aquaculture medicines and personal care products.
dc.typeResearch report
dc.rights.holder© NILU
dc.source.issue13/2009
dc.relation.projectNILU:108105


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record